Abstract

The benefits and risks of abciximab, eptifibatide, or tirofiban during PCI: Class effects or do they differ?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call